UNC child neurologist finds potential route to better treatments for Fragile X, autism

UNC School of Medicine researchers led by neurologist C.J. Malanga, describes a major reason why current medications only moderately alleviate Fragile X symptoms. His team discovered that three specific drugs affect three different kinds of neurotransmitter receptors that all seem to play roles in Fragile X. As a result, current Fragile X drugs have limited benefit because most of them only affect one receptor.

Fuente : http://www.eurekalert.org/pub_releases/2013-10/uon…